larotrectinib
bayer
['lcsm,(-blcsm)', 'hncsm', 'crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'scmsm', 'larotrectinib']
larotrectinib shows sustained efficacy, safety benefit in cns trk fusion cancer #asco22 #scmsm #lcsm #crcsm #hncsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.